The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation

International Journal of Cancer

Volumn 131, Issue 7, 2012, Pages

  Morelli, Maria Beatrice ^a   Nabissi, Massimo ^a   Amantini, Consuelo ^a   Farfariello, Valerio ^a,b   Ricci Vitiani, Lucia ^c   Di Martino, Simona ^c   Pallini, Roberto ^d   Larocca, Luigi Maria ^d   Caprodossi, Sara ^a   Santoni, Matteo ^a   De Maria, Ruggero ^c   Santoni, Giorgio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

differentiation; glioblastoma; glioblastoma stem like cells; TRP; TRPV2

Indexed keywords

BETA TUBULIN; EGTAZIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; NESTIN; PHORBOL 13 ACETATE 12 MYRISTATE; RUTHENIUM RED; VANILLOID RECEPTOR 2;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE; GENE OVEREXPRESSION; GENE SILENCING; GLIA CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MACROGLIA; MALE; MITOSIS INDEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRPV2 GENE; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; PHORBOL ESTERS; TRPV CATION CHANNELS;

EID: 84864460084     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27588     Document Type: Article

References (45)

1. Maher EA, Furnari FB, Bachoo RM, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001; 15: 1311-33.
2. Sanai N, Alvarez-Buylla A, Berger MS,. Neural stem cells and the origin of glioma. N Engl J Med 2005; 353: 811-22.
3. Vescovi AL, Galli R, et al. Brain tumor stem cells. Nat Rev Cancer 2006; 6: 425-36.
4. Ignatova T, Kukekov VG, Laywell ED, et al. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002; 39: 193-206.
5. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003; 100: 15178-83.
6. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-21.
7. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-8.
8. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
9. Kondo T, Setoguchi T, Taga T,. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004; 101: 781-6.
10. Patrawala L, Calhoun T, Schneider-Broussard R, et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005; 65: 6207-19.
11. Dirks PB,. Cancer: stem cells and brain tumors. Nature 2006; 444: 687-8.
12. Campos B, Wan F, Farhadi M, et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010; 16, 2715-28.
13. Prevarskaya N, Zhang L, Barritt G,. TRP channels in cancer. Biochim Biophys Acta 2007; 1772: 937-46.
14. Bödding M,. TRP proteins and cancer. Cell Signal 2007; 19: 617-24.
15. Caprodossi S, Lucciarini R, Amantini C, et al. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage. Eur Urol 2008; 54: 612-20.
16. Amantini C, Ballarini P, Caprodossi S, et al. Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis 2009; 30: 1320-9.
17. Nabissi M, Morelli MB, Amantini C, et al. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner. Carcinogenesis 2010; 31: 794-803.
18. Caterina MJ, Rosen TA, Tominaga M, et al. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 1999; 398: 436-41.
19. Muraki K, Iwata Y, Katanosaka Y, et al. TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes. Circ Res 2003; 93: 829-38.
20. Zimmermann K, Leffler A, Fischer MM, et al. The TRPV1/2/3 activator 2-aminoethoxydiphenyl borate sensitizes native nociceptive neurons to heat in wild type but not TRPV1 deficient mice. Neuroscience 2005; 135: 1277-84.
21. Qin N, Neeper MP, Liu Y, et al. TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci 2008; 28: 6231-8.
22. Kowase T, Nakazato Y, Yoko-O H, et al. Immunohistochemical localization of growth factor-regulated channel (GRC) in human tissues. Endocr J 2002; 49: 349-55.
23. Saunders CI, Kunde DA, Crawford A, et al. Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood. Mol Immunol 2007; 44: 1429-35.
24. Kanzaki M, Zhang YQ, Mashima H, et al. Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I. Nat Cell Biol 1999; 1: 165-70.
25. Penna A, Juvin V, Chemin J, et al. PI3-kinase promotes TRPV2 activity independently of channel translocation to the plasma membrane. Cell Calcium 2006; 39: 495-507.
26. Monet M, Gkika D, Lehen'kyi V, et al. Lysophospholipids stimulate prostate cancer cell migration via TRPV2 channel activation. Biochim Biophys Acta 2009; 1793: 528-39.
27. Monet M, Lehen'kyi V, Gackiere F, et al. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. Cancer Res 2010; 70: 1225-35.
28. Liu G, Xie C, Sun F, et al. Clinical significance of transient receptor potential vanilloid 2 expression in human hepatocellular carcinoma. Cancer Genet Cytogenet 2010; 197: 54-9.
29. Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 2010; 468: 824-8.
30. Kleihues P, Cavenee WK, eds. Pathology and genetics of tumours of the nervous system, World Health Organization classification of tumours, 2nd edn. Lyon: IARC Press, 2000. 10-21.
31. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P,. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
32. Ricci-Vitiani L, Pallini R, Larocca LM, et al. Mesenchymal differentiation of glioblastoma stem cells. Cell Death Differ 2008; 15: 1491-8.
33. Ricci-Vitiani L, Pedini F, Mollinari C, et al. Absence of caspase 8 and high expression of PED protect primitive neural cells from cell death. J Exp Med 2004; 200: 1257-66.
34. Pallini R, Ricci-Vitiani L, Bez A, et al. Homologous transplantation of neural stem cells to the injured spinal cord of mice. Neurosurgery 2005; 57: 1014-25.
35. Szallasi A, Blumberg PM,. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51: 159-212.
36. Aeder SE, Martin PM, Soh JW, et al. PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways. Oncogene 2004; 23: 9062-9.
37. Ho A, Fusenig N,. Cancer stem cells: a promising concept and therapeutic challenge. Int J Cancer 2011; 129: 2309.
38. Jang T, Litofsky NS, Smith TW, et al. Aberrant nestin expression during ethylnitrosurea-(ENU)-induced neurocarcinogenesis. Neurobiol Dis 2004; 15: 544-52.
39. Englund C, Alvord EC, Folkerth RD, et al. NeuN expression correlates with reduced mitotic index of neoplastic cells in central neurocytomas. Neuropathol Appl Neurobiol 2005; 31: 429-38.
40. McFerrin MB, Sontheimer H,. A role for ion channels in glioma cell invasion. Neuron Glia Biol 2006; 2: 39-49.
41. McLendon RE, Friedman AH, Gray L,. Glioblastoma, 7th edn. London: Hodder Arnold, 2006.
42. Kawano H, Kubota T, Sato K, et al. Immunohistochemical study of giant cell in glioblastoma. Clin Neuropathol 1995; 14: 118-23.
43. Ohgaki H, Biernat W, Reis R, et al. Gliosarcoma. In:, Kleihues P, Cavenee WK, eds. Pathology and genetics of tumours of the nervous system, World Health Organization classification of tumours. Lyon: IARC Press, 2000. 40-41.
44. Bomben VC, Sontheimer H,. Inhibition of transient receptor potential canonical channels impairs cytokinesis in human malignant gliomas. Cell Prolif 2008; 41: 98-121.
45. Bomben VC, Sontheimer H,. Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas. Glia 2010; 58: 1145-56.